Adrian Cheng
Angel Investor @ C Ventures
Adrian Cheng is a Series A investor at C Ventures focused on Fashion and Health Care.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 35%
Last updated:
For AI agents: llms.txt
Industries Adrian Cheng invests in
Stages Adrian Cheng invests in
Countries Adrian Cheng invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $2.9M–$102M
- Series B
- $60M–$100M
Investment Focus
Industry
- Fashion 4 (15%)
- Health Care 4 (15%)
- Biotechnology 4 (15%)
- Artificial Intelligence 4 (15%)
- Retail 2 (8%)
Stage
- Series A 7 (27%)
- Series B 6 (23%)
- Venture - Series Unknown 4 (15%)
- Post-IPO Equity 3 (12%)
- Angel 1 (4%)
Country
- United States 11 (42%)
- China 6 (23%)
- United Kingdom 3 (12%)
- Hong Kong 2 (8%)
- Italy 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CBCX provides multi-asset liquidity and trading solutions for brokers and institutions through advanced platforms and APIs. | Oct 27, 2025 | ||
| Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed byACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’. | $48M / Post-IPO Equity / Oct 27, 2025 | ||
| Crisp Momentum is a global media company focused on IP monetisation through innovative short-scripted video content. It produces a wide range of vertical video content across multiple genres, including romance, sports, animation, and many other categories. Crisp Momentum primarily targets and offers in delivering short-form content labelled in avariety of genres, significantly expanding its potential target audience. | Post-IPO Equity / Oct 09, 2025 | ||
| Powering web3 narrative universes via story legos | $80M / Series B / Aug 21, 2024 | ||
| The brand was created by Matthew Williams, based on the idea of using premium materials combined with subversive culture. | Angel / Nov 17, 2023 | ||
| NaaS Technology is a provider of electric vehicle charging services for operators and owners. The company also offers one-stop services to charging pile manufacturers and operators, OEMs, companies with their own delivery fleets, and fleet operators, covering the entire value chain across the EV sector with online, offline, and non-electricservices. It had linked 290,000 chargers, with an annual charging capacity of more than 1,200 gigatonnes.NaaS Technology aims to make charging facilities more efficient and to incorporate this into structural changes to China's energy infrastructure, achieving an important step toward carbon neutrality. | $21M / Post-IPO Equity / May 30, 2023 | ||
| Micro Connect provides market infrastructure, fintech, and platform development. | $70M / Series B / Mar 31, 2022 | ||
| Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. The company focuses on product integration and user experience, aiming to create a digital ecosystem through hardware and software development. | $70M / Series B / Mar 09, 2022 | ||
| The Sandbox is a decentralized, community-driven platform, where creators can make voxel assets and gaming experiences and monetize them on the blockchain. It features 3 main components: an NFT builder, a Marketplace, and Game Maker. | Venture - Series Unknown / Dec 09, 2021 | ||
| Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer. Founded by a cadre of pre-eminent scientific luminaries, including Dr. Tak W. Mak, the Company's robust, internally developed pipeline includes a first-in-class PLK4 kinase inhibitor, CFI-400945, and abest-in-class TTK inhibitor, CFI-402257, and CFI-402411, an oral immunomodulatory kinase inhibitor with activity toward HPK1. Treadwell also has a robust pre-clinical pipeline with multiple biologic and next-generation TCR-based autologous cell therapy programs. | $91M / Series B / Nov 18, 2021 | ||
| See all 26 investments → | |||
Co-Investors
About C Ventures
Co-founded by entrepreneur Adrian Cheng and veteran investor Clive Ng, C Ventures is a global venture capital bridging the West and the East, curating a global cultural ecosystem targeting Millennials and the generation Z with a focus on disruptive businesses in technology, lifestyle and media.
C Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adrian Cheng
Founding Partner
|
|||
Clive Ng
Founding Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Adrian Cheng invest in?
Adrian Cheng invests primarily in Fashion, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Adrian Cheng's check size?
Adrian Cheng typically joins rounds of $2.9M–$102M at Series A and $60M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Adrian Cheng participates in.
How do I contact Adrian Cheng?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Adrian Cheng last invest?
The most recent investment recorded for Adrian Cheng closed in Oct 2025. Shizune tracks 26 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
